DEXCOM INC. DL-,001/ US2521311074 /
5/24/2024 8:00:11 AM | Chg. -5.30 | Volume | Bid9:59:58 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
115.86EUR | -4.37% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 46.72 bill.EUR | - | - |
GlobeNewswire
4/8
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
1/31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.